Optical coherence tomography in Huntington's disease: a potential biomarker for cognitive decline?

被引：0
|
作者：
Monteiro, A. [1 ]
Costa, A. [1 ]
Andrade, C. [1 ]
Beato, J. [2 ]
Penas, S. [2 ]
Guimaraes, J. [1 ]
Reis, F. [2 ]
Garrett, C. [1 ]
机构：
[1] Ctr Hosp Sao Joao, Neurol, Oporto, Portugal
[2] Ctr Hosp Sao Joao, Ophthalmol, Oporto, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2015年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1234
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [31] Optical coherence tomography and cognitive dysfunction in Parkinson disease
    Takwa H. M. Elkhatib
    Noha A. Hashim
    Engy M. Emad
    Hossam Zein
    Lamiaa El-aidy
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 55
  • [32] Is retinal optical coherence tomography an imaging biomarker for Parkinson disease?
    Ascaso, Francisco
    Jimenez, Beatriz
    Lopez del Val, Javier
    Pinilla Lozano, Isabel
    Perez-Garcia, Diana
    Ibanez-Alperte, Juan
    Cristobal, Jose
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [33] Psychiatric features in relation to cognitive decline in Huntington's disease
    Soliveri, P.
    Paridi, D.
    Mariotti, C.
    Di Donato, S.
    Albanese, A.
    Girotti, F.
    MOVEMENT DISORDERS, 2006, 21 : S360 - S360
  • [34] Progression of global cognitive decline in individuals with Huntington's disease
    Hamilton, JM
    Corey-Bloom, J
    Wolfson, T
    Jacobson, MW
    Wetter, SR
    Goldstein, J
    Peauy, GM
    NEUROLOGY, 2005, 64 (06) : A91 - A91
  • [35] Cognitive decline in Huntington's disease expansion gene carriers
    Baake, Verena
    Reijntjes, Robert H. A. M.
    Dumas, Eve M.
    Thompson, Jennifer C.
    Roos, Raymund A. C.
    CORTEX, 2017, 95 : 51 - 62
  • [36] Serum Cathepsin D Is a Potential Biomarker for Alzheimer's Disease Dementia and Cognitive Decline
    Chai, Yuek Ling
    Liang, Nathan Hao Ping
    Chong, Joyce R.
    Venketasubramanian, Narayanaswamy
    Tan, Boon Yeow
    Hilal, Saima
    Chen, Christopher P.
    Lai, Mitchell K. P.
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 91 (03) : 989 - 998
  • [37] Optical Coherence Tomography Angiography Based Capillary Density as a Biomarker for Assessment of Cognitive Impairment in Alzheimer's Disease and Related Dementias
    Kashani, Amir
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [38] No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset
    Schmid, Rahel Dominique
    Remlinger, Jana
    Abegg, Mathias
    Hoepner, Robert
    Hoffmann, Rainer
    Lukas, Carsten
    Saft, Carsten
    Salmen, Anke
    BRAIN AND BEHAVIOR, 2022, 12 (06):
  • [39] The association of vitreous biomarker levels and optical coherence tomography markers to cognitive status
    Sheikh, Zahra
    Davoudi, Samaneh
    Siegel, Nicole
    Ness, Steven
    Chen, Xuejing
    Xi, Weiming
    Alosco, Michael
    Alluri, Sreevardhan
    Regis, Katherine
    Phalaari, Stuti
    Stein, Thor
    Subramanian, Manju
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [40] A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography
    Slotnick, Samantha
    Ding, Yin
    Glazman, Sofya
    Durbin, Mary
    Miri, Shahnaz
    Selesnick, Ivan
    Sherman, Jerome
    Bodis-Wollner, Ivan
    MOVEMENT DISORDERS, 2015, 30 (12) : 1692 - 1695
12345